CARMEL,
Ind., Oct. 17, 2023 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare
company with a mission to improve healthcare by providing
innovative services and technology solutions, announced today a
two-year contract extension, worth up to $636,000, with the Indiana Division of Mental
Health and Addiction and Family and Social Services Administration
(FSSA) to chair and manage the State of
Indiana's Epidemiological Outcomes Workgroup (SEOW).
Through the contract extension, Syra Health will continue
to collect and analyze substance use and misuse data throughout
Indiana. Syra Health then develops
data-driven reports and recommendations to inform and improve
Indiana's long-term substance
misuse prevention policy.
"Our qualitative and quantitative research methodologies and
data-driven approaches to the SEOW contract helped us to secure
this extension and have enabled us to win similar epidemiological
study contracts in other states," said Dr. Deepika Vuppalanchi, CEO, Syra Health.
As part of this work, Syra Health's epidemiologists and public
health experts identify emerging substance use trends in the state
and promote behavioral and mental health improvements.
"Working together with 20 different state agencies and
divisions, we have the unique opportunity to provide a holistic
picture of the behavioral health needs for the State of Indiana," said Dr. Srikant Devaraj , Vice President of Health
Analytics, Syra Health.
ABOUT SYRA HEALTH CORP.
Syra Health is a healthcare company with a mission to improve
healthcare by providing innovative services and technology
solutions. Syra Health aims to achieve its goal by becoming a
valuable partner to government, payers, providers, life sciences
organizations, and academic institutions. Syra Health offers
products and services in digital health, behavioral and mental
health, population health management, health education, and
healthcare workforce. For more information, please visit
www.syrahealth.com.
SAFE HARBOR STATEMENT
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include, but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty and changes in circumstances. Actual results may
differ materially from those indicated by such forward-looking
statements as a result of various important factors discussed in
the "Risk Factors" section of the prospectus filed with the SEC.
Any forward-looking statements contained in this press release
speak only as of the date hereof, and, except as required by
federal securities laws, the Company specifically disclaims any
obligation to update any forward-looking statements, whether as a
result of new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine Drury
Communications and Marketing Director
Syra Health Corp.
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original
content:https://www.prnewswire.com/news-releases/syra-health-secures-two-year-extension-of-indianas-epidemiological-outcomes-workgroup-contract-301958976.html
SOURCE Syra Health